BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 32319381)

  • 1. [Application of CpG Oligodeoxynucleotide Immunostimulation in Chromosome Study of Chronic Lymphoblastic Leukemia].
    Mai DI Na AEK; Liu H; Wang YL; Wang YC; Huang Q; Wang ZS; Gu ZLNE; Lang T; Nie YL; An L; A ZGL; Mu HTBE; Zhang XY; Fu L; Ai HMJ; Mao M; Wang XM; Li Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Apr; 28(2):470-475. PubMed ID: 32319381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunostimulation by cytosine-phosphate-guanine oligodeoxynucleotides in combination with IL-2 can improve the success rate of karyotype analysis in chronic lymphocytic leukaemia.
    Lin X; Chen J; Huang H
    Br J Biomed Sci; 2016 Jul; 73(3):110-114. PubMed ID: 27327088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Chromosome study on chronic lymphocytic leukemia using CpG-oligodeoxynucleotide as immunostimulant agent].
    Wu Y; Xue Y; Chen S; Yao L; Jiang H; Zhang J; Shen J; Pan J; Wang Y; Bai S
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2010 Feb; 27(1):86-91. PubMed ID: 20140876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Chromosomal aberrations detection in chronic lymphocytic leukemia by conventional cytogenetics using DSP30 and IL-2].
    Liu HF; Huang HW; Bai SX; Gong YL; Wu CX; Jin ZM; Wang YY; Yang Q; Zhang J; Qiu HY; Chen SN; Pan JL
    Zhonghua Xue Ye Xue Za Zhi; 2020 Feb; 41(2):143-148. PubMed ID: 32135632
    [No Abstract]   [Full Text] [Related]  

  • 5. CpG Oligonucleotide and Interleukin 2 stimulation enables higher cytogenetic abnormality detection rates than 12-o-tetradecanolyphorbol-13-acetate in Asian patients with B-cell chronic lymphocytic leukemia (B-CLL).
    Liaw FP; Lau LC; Lim AS; Lim TH; Lee GY; Tien SL
    Int J Hematol; 2014 Dec; 100(6):545-53. PubMed ID: 25301672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved detection rate of cytogenetic abnormalities in chronic lymphocytic leukemia and other mature B-cell neoplasms with use of CpG-oligonucleotide DSP30 and interleukin 2 stimulation.
    Shi M; Cipollini MJ; Crowley-Bish PA; Higgins AW; Yu H; Miron PM
    Am J Clin Pathol; 2013 May; 139(5):662-9. PubMed ID: 23596118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of DSP30-IL2/TPA for detection of cytogenetic abnormalities in chronic lymphocytic leukaemia/small lymphocytic lymphoma.
    Holmes PJ; Peiper SC; Uppal GK; Gong JZ; Wang ZX; Bajaj R
    Int J Lab Hematol; 2016 Oct; 38(5):483-9. PubMed ID: 27565124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cytogenetics of chronic lymphocytic leukemia stimulated by CpG-oligodeoxynucleotides and IL-2].
    Wang DM; Xu W; Dong HJ; Fang C; Zhu DX; Cao X; Zhu HY; Zhuang Y; Qiu HR; Yang H; Li JY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Oct; 18(5):1114-8. PubMed ID: 21129242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulation of chronic lymphocytic leukemia cells with CpG oligodeoxynucleotide gives consistent karyotypic results among laboratories: a CLL Research Consortium (CRC) Study.
    Heerema NA; Byrd JC; Dal Cin PS; Dell' Aquila ML; Koduru PR; Aviram A; Smoley SA; Rassenti LZ; Greaves AW; Brown JR; Rai KR; Kipps TJ; Kay NE; Van Dyke DL;
    Cancer Genet Cytogenet; 2010 Dec; 203(2):134-40. PubMed ID: 21156225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chromosome banding analysis of peripheral blood lymphocytes stimulated with IL2 and CpG oligonucleotide DSP30 in patients with chronic lymphocytic leukemia].
    Stěpanovská K; Vaňková G; Némethová V; Tomášiková L; Smuhařová P; Divíšková E; Vallová V; Kuglík P; Plevová K; Oltová A; Doubek M; Pospíšilová S; Mayer J
    Klin Onkol; 2013; 26(4):263-70. PubMed ID: 23961857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Detection of Gene Abnormalities in 43 Cases of Chronic Lymphocytic Leukemia by Fluorescence in Situ Hybridization].
    Jing Y; Lin S; Wang FT; Yu JW; Jiang F
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Aug; 26(4):1038-1043. PubMed ID: 30111404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved detection of chromosomal abnormalities in chronic lymphocytic leukemia by conventional cytogenetics using CpG oligonucleotide and interleukin-2 stimulation: A Belgian multicentric study.
    Put N; Konings P; Rack K; Jamar M; Van Roy N; Libouton JM; Vannuffel P; Sartenaer D; Ameye G; Speleman F; Herens C; Poirel HA; Moreau Y; Hagemeijer A; Vandenberghe P; Michaux L;
    Genes Chromosomes Cancer; 2009 Oct; 48(10):843-53. PubMed ID: 19582829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunostimulatory CpG-oligonucleotides induce functional high affinity IL-2 receptors on B-CLL cells: costimulation with IL-2 results in a highly immunogenic phenotype.
    Decker T; Schneller F; Kronschnabl M; Dechow T; Lipford GB; Wagner H; Peschel C
    Exp Hematol; 2000 May; 28(5):558-68. PubMed ID: 10812246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunostimulatory oligonucleotide-induced metaphase cytogenetics detect chromosomal aberrations in 80% of CLL patients: A study of 132 CLL cases with correlation to FISH, IgVH status, and CD38 expression.
    Dicker F; Schnittger S; Haferlach T; Kern W; Schoch C
    Blood; 2006 Nov; 108(9):3152-60. PubMed ID: 16840733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensitization of B-cell chronic lymphocytic leukemia cells to recombinant immunotoxin by immunostimulatory phosphorothioate oligodeoxynucleotides.
    Decker T; Hipp S; Kreitman RJ; Pastan I; Peschel C; Licht T
    Blood; 2002 Feb; 99(4):1320-6. PubMed ID: 11830482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The parallel application of karyotype interphase and metaphase FISH after DSP-30/IL-2 stimulation is necessary for the investigation of chronic lymphocytic leukemia.
    Karakosta M; Manola KN
    Hematology; 2016 Oct; 21(9):526-35. PubMed ID: 27077766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive genetic characterization of CLL: a study on 506 cases analysed with chromosome banding analysis, interphase FISH, IgV(H) status and immunophenotyping.
    Haferlach C; Dicker F; Schnittger S; Kern W; Haferlach T
    Leukemia; 2007 Dec; 21(12):2442-51. PubMed ID: 17805327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromosomal aberrations in chronic lymphocytic leukemia detected by conventional cytogenetics with DSP30 as a single agent: comparison with FISH.
    Kotkowska A; Wawrzyniak E; Blonski JZ; Robak T; Korycka-Wolowiec A
    Leuk Res; 2011 Aug; 35(8):1032-8. PubMed ID: 21333354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interphase Molecular Cytogenetic Detection Rates of Chronic Lymphocytic Leukemia-Specific Aberrations Are Higher in Cultivated Cells Than in Blood or Bone Marrow Smears.
    Alhourani E; Aroutiounian R; Harutyunyan T; Glaser A; Schlie C; Pohle B; Liehr T
    J Histochem Cytochem; 2016 Aug; 64(8):495-501. PubMed ID: 27315825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chromosomal aberrations in chronic lymphocytic leukemia by interphase fluorescence in situ hybridization and their association with clinical features].
    Li WJ; Guo L; Hou M; Sun JZ; Shao LL; Wang SK; Ma DX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Apr; 18(2):494-8. PubMed ID: 20416197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.